SafeHeal’s Jenny Gaffney to Address Medicare Reimbursement at The MedTech Conference 2025
Chris Richardson, CEO of SafeHeal, will be presenting an overview of the benefits of Colovac to strategic partners....
SafeHeal® Receives European Marketing Approval Under MDR for Colovac® Anastomosis Protection Technology
SafeHeal announced that it has been granted European Union marketing approval for its Colovac device under the new Medical Device Regulation (EU MDR 2017/745, Medical Devices, Annex IX Chapter I)....
SafeHeal® Closes Oversubscribed €35 Million Series C Equity Financing
Breakthrough device promises significantly improved patient recovery after colorectal surgery....
SafeHeal Receives Breakthrough Device designation for Colovac Endoluminal Bypass Sheath
Breakthrough device promises significantly improved patient recovery after colorectal surgery....
Chief Executive Officer Chris Richardson to Speak at LSI Emerging Medtech Summit
Chris Richardson, CEO of SafeHeal, will be presenting an overview of the benefits of Colovac to strategic partners....
SafeHeal appoints medical device industry veteran Chris Richardson as Chief Executive Officer
Breakthrough device promises significantly improved patient recovery after colorectal surgery....
SafeHeal Completes First-in-Human Clinical Study of Endoluminal Bypass Sheath
SafeHeal, an innovator in the field of digestive surgery, has concluded its first-in-human clinical study for its novel Colovac bypass sheath in patients undergoing colorectal surgery....
SAFEHEAL starts first-in-human and CE-mark clinical study of endoluminal bypass sheath with the potential of replacing ostomy
The study will evaluate safety and efficacy of the Colovac bypass device for ostomy-free anastomosis protection following colorectal surgery....